Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Oct 25, 2011

Premium

David Macdonald has been named CEO at Agendia. He replaces Bernhard Sixt, who led the Dutch diagnostics firm since its founding in 2003. Sixt will remain with Agendia in an "advisory capacity," Agendia said.

Macdonald has served as Agendia's chief operating officer since last year. He previously worked at Quest Diagnostics, Behring Diagnostics, and Novo Medical. Macdonald holds a BS in management and finance from Northeastern University and an MBA from Babson College.

Agendia also said that Colin Goddard has joined its supervisory board of directors. Goddard is CEO of Coferon.


GenomeQuest has appointed Heidi Rehm, Madhuri Hegde, and Shashikant Kulkarni to its clinical advisory board.

Rehm is a molecular geneticist and assistant professor of pathology at Harvard Medical School. Hegde is an associate professor at the Emory University School of Medicine Department of Human Genetics and scientific director of the Emory Genetics Laboratory. She has also played a role in the development of several molecular testing panels commercialized by Oxford Gene Technology (BAN 8/23/2011). Kulkarni is medical director of genomics and pathology services and medical director of cytogenomics and molecular pathology at Washington University School of Medicine.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.